Summary
In a population-based survey of 2,930 subjects, prevalence rates for obesity, Type 2 (non-insulin-dependent) diabetes mellitus, impaired glucose tolerance, hypertension, hypertriglyceridaemia, and hypercholesterolaemia were 54.3, 9.3, 11.1, 9.8, 10.3 and 9.2%, respectively. The prevalence, however, of each of these conditions in its isolated form (free of the other five) was 29.0% for obesity, 1.3% for Type 2 diabetes, 1.8% for impaired glucose tolerance, 1.5% for hypertension, 1.0% for hypertriglyceridaemia, and 1.7% for hypercholesterolaemia. Two-by-two associations were even rarer. The large differences in prevalence between isolated and mixed forms indicate a major overlap among the six disorders in multiple combinations. In the isolated form, each condition was characterized by hyperinsulinaemia (both fasting and 2 h after oral glucose), suggesting the presence of insulin resistance. In addition, in any isolated condition most of the variables categorising other members of the sextet were still significantly altered in comparison with 1,049 normal subjects. In the whole of the subjects who presented with one or another disorder (1,881 of 2,930 or 64%), marked fasting and post-glucose hyperinsulinaemia was associated with higher body mass index, waist:hip ratio, fasting and post-glucose glycaemia, systolic and diastolic blood pressure, serum triglycerides and total cholesterol levels, and with lower HDL-cholesterol concentrations (all p <0.001). We conclude that (1) insulin sensitivity, glucose tolerance, blood pressure, body fat mass and distribution, and serum lipids are a network of mutually interrelated functions; and (2) an insulin resistance syndrome underlies each and all of the six disorders carrying an increased risk of coronary artery disease.
Article PDF
Similar content being viewed by others
References
Sims EAH, Berchtold P (1982) Obesity and hypertension. Mechanisms and implications for management. JAMA 247: 49–52
National Diabetes Data Group (1979) Classification of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1055
Fuller JH (1985) Epidemiology of hypertension associated with diabetes mellitus. Hypertension 7 [Suppl. II]: II3–7
Nikkila EA (1984) Plasma lipid and lipoprotein abnormalities in diabetes. In: Jarrett RJ (ed) Diabetes and heart disease. Elsevier, Amsterdam, pp 133–167
Stamler J, Berkson D, Dyer A, Lindberg HA (1975) Relationship of multiple variables to blood pressure findings from four Chicago epidemiologic studies. In: Paul O (ed) Epidemiology and control of hypertension. Stratton, New York, pp 307–356
Modan M, Halkin H, Almog S, Lusky A, Eskol A, Shefi M, Shitrit A, Fuchs L (1985) Hyperinsulinaemia. A link between hypertension obesity and glucose intolerance. J Clin Invest 75: 809–817
DeFronzo RA, Ferrannini E (1982) The pathogenesis of non-insulin dependent diabetes. An update. Medicine 61: 125–135
Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi LS, Bevilacqua S (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350–357
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595–1607
Castelli WP (1984) Epidemiology of coronary heart disease: the Framingham study. Am J Med 76 [Suppl. 2A]: 4–12
Stamler R, Stamler J (1979) Asymptomatic hyperglycemia and coronary heart disease. J Chron Dis 32: 829–837
Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, Speizer FE, Hennekens CH (1990) A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 322: 882–889
Pyőrala K (1979) Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2: 121–141
Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G (1980) Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19: 205–210
Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK (1986) Hyperinsulinaemia in a population at high risk for non-insulin-dependent diabetes mellitus. N Engl J Med 315: 220–224
Hazuda HP, Comeaux PJ, Stern MP, Haffner SM, Eifler CW, Rosenthal M (1986) A comparison of three indicators for identifying Mexican Americans in epidemiologic research: methodological findings from the San Antonio Heart Study. Am J Epidemiol 123: 96–112
Stern MP, Patterson JK, Mitchell BD, Haffner SM, Hazuda HP (1990) Overweight and mortality in Mexican Americans. Int J Obes 14: 623–629
Hypertension Detection and Follow-up Program Cooperative Group (1977) Blood pressure studies in 14 communities: a two-stage screen for hypertension. JAMA 237: 2385–2391
World Health Organization Expert Committee (1980) Second Report on Diabetes Mellitus. Geneva, WHO, Tech. Rep. Ser. No. 646
Tobey TA, Greenfield M, Kraemer F, Reaven GM (1981) Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism 30: 165–171
Reaven GM, Lerner RL, Stern MP, Farquhar JW (1967) Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 46: 1756–1767
Steiner G, Vranic M (1982) Hyperinsulinemia and hypertriglyceridemia, a vicious circle with atherogenic potential. Int J Obes 6 [Suppl. 1]: 117–124
Ferrannini E, DeFronzo RA (1989) The association of hypertension, diabetes, and obesity: a review. J Nephrol 1: 3–15
DeFronzo RA (1988) The triumvirate: ß-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37: 667–687
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223
Kolterman OG, Insel J, Saekow M, Olefsky JM (1980) Mechanisms of insulin resistance in human obesity. Evidence for receptor and postreceptor defects. J Clin Invest 65: 1272–1284
Groop LC, Bonadonna RC, Del Prato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA (1989) Glucose and free fatty acid metabolism in non-insulin dependent diabetes mellitus: evidence for multiple sites of insulin resistance. J Clin Invest 84: 205–213
Bogardus C, Lillioja S, Howard B, Reaven GM, Mott D (1984) Relationships between insulin secretion, insulin action and fasting plasma glucose concentration in non-diabetic and non-insulin-dependent diabetic subjects. J Clin Invest 74: 1238–1246
Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C (1988) Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318: 1217–1225
Steiner G, Morita S, Vranic M (1980) Resistance to insulin but not glucagon in lean human hypertriglyceridemics. Diabetes 29: 899–905
Shen DC, Shieh S-M, Fuh MT, Chen Y-DI, Reaven GM (1988) Resistance to insulin-stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 66: 580–583
Lind L, Jakobsson S, Lithell H, Wengle B, Ljunghall S (1988) Relation of serum calcium to metabolic risk factors for cardiovascular disease. Br Med J 297: 960–963
Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WGH, Knowler WC, Bennett PH, Moll P, Bogardus C (1987) In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 36: 1329–1335
Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK (1988) Increased insulin concentrations in nondiabetic offspring of diabetic parents. N Engl J Med 319: 1297–1301
Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321: 337–343
Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK (1990) Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 39: 283–288
Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK, Ferrannini E (1989) Parental history of diabetes is associated with increased cardiovascular risk factors. Arteriosclerosis 9: 928–933
Zavaroni I, Bonora E, Pagliara M et al. (1989) Risk factors for coronary artery disease in healthy people with hyperinsulinaemia and normal glucose tolerance. N Engl J Med 320: 202–206
Hurt SC, Wu LL, Hopkins PN et al. (1989) Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension. Arteriosclerosis 9: 335–344
Stunkard AJ, Sorensen TIA, Hanis C, Teasdale TW, Chakraborty R, Schull WJ, Schulsinger F (1986) An adoption study of human obesity. N Engl J Med 314: 193–198
Foster DW (1989) Diabetes mellitus. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited diseases, 6th edn. McGraw-Hill, New York, p 384
Johnson BC, Epstein FH, Kjelsberg M (1965) Distribution and familial studies of blood pressure and serum cholesterol levels in a total community, Tecumseh, Michigan. J Chronic Dis 18: 147–160
Iselius L, Morton NE, Rao DC (1983) Family resemblance for blood pressure. Hum Hered 33: 277–286
Grundy SM (1987) Disorders of lipids and lipoproteins. In: Stein JH (ed) Internal medicine, 2nd edn. Little, Brown and Company, Boston, pp 2035–2052
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ferrannini, E., Haffner, S.M., Mitchell, B.D. et al. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34, 416–422 (1991). https://doi.org/10.1007/BF00403180
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00403180